Krajina: Izrael
Jazyk: angličtina
Zdroj: Ministry of Health
BETAMETHASONE AS VALERATE; FUSIDIC ACID AS HEMIHYDRATE
VETMARKET LTD, ISRAEL
GEL
BETAMETHASONE AS VALERATE 0.1 %; FUSIDIC ACID AS HEMIHYDRATE 0.5 %
TOPICAL
Required
DECHRA VETERINARY PRODUCTS A/S ,DENMARK
For the topical treatment of surface pyoderma in dogs such as acute moist dermatitis ("hot spots") and intertrigo (skin fold dermatitis) in dogs.
2023-05-31
CONSUMER LEAFLET FOR A VETERINARY PRODUCT The medicine is marketed according to a veterinarian's prescription only For use in animals only 1. NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE Isaderm Veterinary, gel for topical skin application in dogs. Betamethasone (as valerate) 0.1% w/w Fusidic Acid (as hemihydrate) 0.5% w/w 2. ACTIVE INGREDIENTS and their quantity per dose unit Betamethasone (as valerate) 0.1% w/w Fusidic Acid (as hemihydrate) 0.5% w/w Each 1 g gel contains: 1 mg Betamethasone (as valerate) 5 mg Fusidic Acid (as hemihydrate) For the list of inactive ingredients and allergens in the product - see section 13 ("Additional information") in this leaflet. 3. WHAT IS THE MEDICINE INTENDED FOR? Topical treatment of surface pyoderma in dogs such as acute moist dermatitis (hot spots) and skin fold dermatitis (intertrigo). Therapeutic group: Potent corticosteroid (Betamethasone) in combination with a bacteriostatic antibiotic (Fusidic Acid). 4. CONTRAINDICATIONS Do not use for the treatment of deep pyoderma. Do not use in pyotraumatic furunculosis and pyotraumatic folliculitis with ”satellite” lesions of papules or pustules. Do not use where fungal or viral infection is already present. Do not apply to the eyes. Do not use over large surface areas, do not use for prolonged treatment. Do not use in dogs with known hypersensitivity to the active ingredients or to any of the inactive ingredients. See section 10 ("Warnings"). 5. SIDE EFFECTS Prolonged and intensive use of topical corticosteroid preparations or treatment of a large cutaneous surface (>10%) is known to trigger local or systemic effects including suppression of adrenal function, thinning of the epidermis and delayed healing of lesions. Locally applied steroids may cause depigmentation of the skin. Discontinue use if hypersensitivity to the product develops. Side effects can be reported to the Ministry of Health by clicking the link "Report side effects due to medication" which can be found on the homepage of the Ministry of Health website Prečítajte si celý dokument